Thornalley PJ - Search Results

1

The potential role of thiamine (vitamin B1) in diabetic complications.

Thornalley PJ. Thornalley PJ. Curr Diabetes Rev. 2005 Aug;1(3):287-98. doi: 10.2174/157339905774574383. Curr Diabetes Rev. 2005. PMID: 18220605 Review.

2

Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine.

Babaei-Jadidi R, Karachalias N, Ahmed N, Battah S, Thornalley PJ. Babaei-Jadidi R, et al. Among authors: thornalley pj. Diabetes. 2003 Aug;52(8):2110-20. doi: 10.2337/diabetes.52.8.2110. Diabetes. 2003. PMID: 12882930

3

Advanced glycation endproducts: what is their relevance to diabetic complications?

Ahmed N, Thornalley PJ. Ahmed N, et al. Among authors: thornalley pj. Diabetes Obes Metab. 2007 May;9(3):233-45. doi: 10.1111/j.1463-1326.2006.00595.x. Diabetes Obes Metab. 2007. PMID: 17391149 Review.

4

High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats.

Babaei-Jadidi R, Karachalias N, Kupich C, Ahmed N, Thornalley PJ. Babaei-Jadidi R, et al. Among authors: thornalley pj. Diabetologia. 2004 Dec;47(12):2235-46. doi: 10.1007/s00125-004-1582-5. Epub 2004 Dec 11. Diabetologia. 2004. PMID: 15662560

5

Emerging role of thiamine therapy for prevention and treatment of early-stage diabetic nephropathy.

Rabbani N, Thornalley PJ. Rabbani N, et al. Among authors: thornalley pj. Diabetes Obes Metab. 2011 Jul;13(7):577-83. doi: 10.1111/j.1463-1326.2011.01384.x. Diabetes Obes Metab. 2011. PMID: 21342411 Review.

6

High-dose thiamine therapy counters dyslipidemia and advanced glycation of plasma protein in streptozotocin-induced diabetic rats.

Karachalias N, Babaei-Jadidi R, Kupich C, Ahmed N, Thornalley PJ. Karachalias N, et al. Among authors: thornalley pj. Ann N Y Acad Sci. 2005 Jun;1043:777-83. doi: 10.1196/annals.1333.090. Ann N Y Acad Sci. 2005. PMID: 16037305

7

High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease.

Thornalley PJ, Babaei-Jadidi R, Al Ali H, Rabbani N, Antonysunil A, Larkin J, Ahmed A, Rayman G, Bodmer CW. Thornalley PJ, et al. Diabetologia. 2007 Oct;50(10):2164-70. doi: 10.1007/s00125-007-0771-4. Epub 2007 Aug 4. Diabetologia. 2007. PMID: 17676306 Free PMC article.

8

Suppression of the accumulation of triosephosphates and increased formation of methylglyoxal in human red blood cells during hyperglycaemia by thiamine in vitro.

Thornalley PJ, Jahan I, Ng R. Thornalley PJ, et al. J Biochem. 2001 Apr;129(4):543-9. doi: 10.1093/oxfordjournals.jbchem.a002889. J Biochem. 2001. PMID: 11275553 Free article.

9

Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes.

Ahmed N, Babaei-Jadidi R, Howell SK, Thornalley PJ, Beisswenger PJ. Ahmed N, et al. Among authors: thornalley pj. Diabetes Care. 2005 Oct;28(10):2465-71. doi: 10.2337/diacare.28.10.2465. Diabetes Care. 2005. PMID: 16186281 Clinical Trial.

10

Increased protein damage in renal glomeruli, retina, nerve, plasma and urine and its prevention by thiamine and benfotiamine therapy in a rat model of diabetes.

Karachalias N, Babaei-Jadidi R, Rabbani N, Thornalley PJ. Karachalias N, et al. Among authors: thornalley pj. Diabetologia. 2010 Jul;53(7):1506-16. doi: 10.1007/s00125-010-1722-z. Epub 2010 Apr 6. Diabetologia. 2010. PMID: 20369223 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

291 results

Search Page